#United States #Elanco Animal Health #Healthcare Conference #Greenfield #Animal Health

Elanco Animal Health to Present at the Upcoming Morgan Stanley Global Healthcare Conference

Elanco Animal Health Incorporated (NYSE: ELAN) is set to participate in the 23rd Annual Global Healthcare Conference organized by Morgan Stanley. This significant event will take place on September 8-9, 2025, where leaders from the animal health industry come together to share insights and innovations that are transforming healthcare for both animals and humans alike.

Event Details

The focus of the conference is to discuss the latest advancements in healthcare, with a spotlight on animal health, a vital area that directly impacts both agricultural practices and veterinary medicine. Elanco's President and CEO, Jeff Simmons, alongside Bob VanHimbergen, the Executive Vice President and CFO, will be featured in a prominent “fireside chat.” This discussion is scheduled for September 9, 2025, at 8:30 a.m. ET, and will allow these leaders to articulate Elanco's vision and initiatives aimed at improving animal health and welfare.

A live audio webcast of the session will be accessible on Elanco's investor website within the “Events and Presentations” section. Additionally, for those unable to attend in real-time, a replay will be available for a limited time afterward, ensuring that stakeholders have the opportunity to engage with the insights shared during the event.

About Elanco

Founded over 70 years ago, Elanco Animal Health is a global frontrunner in the animal health sector, dedicated to innovating and delivering effective products and services for the prevention and treatment of diseases affecting farm animals and household pets. The company's mission is to create value for various stakeholders, including farmers, veterinarians, pet owners, and society at large. Elanco’s commitment to animal health reflects a broader vision: to enrich lives through food safety and companionship.

The company believes in pushing boundaries and striving for progress in every aspect of its operations. Elanco's vision emphasizes the importance of “Food and Companionship Enriching Life,” positioning the company not only as a leader in the creation of high-quality animal health products but also as a responsible community member committed to making a meaningful impact both locally and globally.

Looking Ahead

As the 23rd Annual Global Healthcare Conference approaches, excitement builds around Elanco's participation. With the ongoing challenges in health care for both animals and humans, industry leaders are keen to share strategies for collaboration and innovation that benefit all stakeholders in the animal health ecosystem. This event represents a critical platform for Elanco to unveil future directions, product advancements, and strategic partnerships aimed at enhancing the welfare of animals worldwide.

Stakeholders and the public interested in learning more about Elanco’s innovative solutions and commitments to animal health are encouraged to tune into the live session and engage with the company's offerings through their official website.

In anticipation of the conference, Elanco expresses its commitment to pushing the envelope in animal health and ensuring sustainable solutions that benefit farmers and pet owners alike. This commitment will be more evident as leaders gather to discuss the future of animal health at this pivotal event.

For more details about the conference, visit Elanco's Investor Website or contact Tiffany Kanaga at 765-740-0314 or [email protected]

For media inquiries, reach out to Colleen Parr Dekker at 317-989-7011 or [email protected]